Can partnership with patients be improved to the benefit of healthcare? We think so, and today we launch a strategy to help make it happen. It’s a delivery on a […]
Latest articles
Jim Murray: A surprising development in the case of InterMune vs the EMA
InterMune has withdrawn part of its legal challenge to stop the European Medicines Agency from disclosing certain documents, which relate to the medicine Esbriet (Pirfenidone). The company is still looking for […]
David Kerr: Death in America
In the United States, even the grim reaper is not immune from political interference. Around two weeks ago, an episode of mass murder happened a few miles from where I live. […]
Chris Hopson: You get what you pay for—a different approach to the 2015/16 NHS tariff is crucial
If you get what you pay for, then 2015/16 risks being a very difficult year for the NHS, as the system affordability challenge, according to Monitor, jumps from 3.1% to […]
The BMJ Today: Lifestyle counselling and screening—great expectations and false hopes
The underlying concept of screening is that an early detection of risk factors or disease is beneficial for the clinical or public health outcome. Patients, physicians, and public health authorities […]
Ceinwen Giles: Patient leaders at the NHS Confederation Conference
As readers of The BMJ will know, leadership is a widely discussed and hotly debated topic across the NHS at the moment. It’s also a theme that permeated the NHS […]
Azeem Majeed: Are federations the way forward for general practices in England?
As general practices in England come under increasing workload, funding, and contractual pressures, a new type of primary care organisation—the GP Federation—is becoming more common. The RCGP defines GP federations […]
Richard Lehman’s journal review—9 June 2014
NEJM 5 Jun 2014 Vol 370 2169 There is a story that when new antibiotics were arriving every few weeks in the late 1950s, drug companies had a hard time […]
The BMJ Today: Dying to talk about it—care and conversations near the end of life
Why do we find it so difficult to talk about dying? A question that palliative care specialists, such as Scott Murray and Kirsty Boyd, have been asking ever more urgently as populations […]
Ahmed Rashid: Can we ever be “just friends” with big pharma?
It’s been less than a decade since I started medical school and even in my short career the relationship between doctors and the drug industry has undergone drastic change. During […]